Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Pfizer Announced That Based On Results From The Ongoing Pharmacokinetic Study, The Company Has Selected Its Preferred Once-daily Modified Release Formulation For Danuglipron. Pfizer Plans To Conduct Dose Optimization Studies In The Second Half Of 2024

Author: Benzinga Newsdesk | July 11, 2024 06:50am

Posted In: PFE

08/02/2024 Humana Inc. (HUM)